Leading Research Center serving the Greater Sherman Area
Join a Clinical Trial
ASTHMA: Flair Study
The FLAIR Study is evaluating an investigational drug to see how it works in reducing the severity and frequency of “asthma attacks” in children, adolescents, and adults. The investigational drug will be administered using an inhaler device.
f you have had a COPD exacerbation in the last 12 months that required medical attention, you may qualify to participate in a clinical research study. We are testing new investigational therapies to find out if they can reduce airway inflammation and improve COPD symptoms.
You may want to consider participating in the HERMES study, evaluating a new investigational drug for its ability to treat inflammation which may have a positive effect on heart failure.
New investigational treatment option for patients with atrial fibrillation who are unable or unwilling to take currently available blood thinners to help reduce the risk of stroke.
The purpose of this study is to evaluate how the body responds to the combination of ensifentrine and glycopyrrolate, both together and individually. The study medication is administered as an inhaled treatment and may help open the airways and reduce inflammation in the lungs.
Participating in a clinical trial gives patients access to medications of the future for the diseases of today.
By meeting with our research team for a prescreening appointment, we can discuss which research programs you may be eligible for. These programs are at no cost to patients and do not involve their insurance. Some programs may reimburse patients for their participation.
Pharmaceutical Sponsor?
We have worked with sponsors such as AstraZeneca, Pfizer, Glaxo Smith Kline, Rebiotix, Novo Nordisk, and Janssen.
If you are a sponsor who would like to learn more about our site:
.png){kind=small}
